Greenwich LifeSciences, Inc. GLSI

$18.70 +35.90% at last close

Analyst Consensus

Consensus Rating
Buy (1 Buy · 0 Hold · 0 Sell)
Average Price Target
$70.00
Implied Upside
+274.3%
Price Target Range
$70.00 – $70.00
Analysts (12 mo)
1

Recent Analyst Actions

DateFirmActionRatingPrice Target
2026-11-18
HC Wainwright & Co.Yi Chen
Maintains Buy $69 → $70
2026-07-21
HC Wainwright & Co.Yi Chen
Maintains Buy $50 → $69
2025-12-30
HC Wainwright & Co.Yi Chen
Maintains Buy $39 → $50
2025-04-21
HC Wainwright & Co.Yi Chen
Maintains Buy $38 → $39
2025-02-11
HC Wainwright & Co.Yi Chen
Reiterates Buy $38
2024-08-23
HC Wainwright & Co.Yi Chen
Maintains Buy $36 → $38
2024-05-22
HC Wainwright & Co.Yi Chen
Reiterates Buy $36
2024-02-28
HC Wainwright & Co.Yi Chen
Reiterates Buy $36
2024-02-20
HC Wainwright & Co.Yi Chen
Maintains Buy $38 → $36
2023-04-10
HC Wainwright & Co.Yi Chen
Reiterates Buy $78 → $38
2021-09-01
HC Wainwright & Co.Yi Chen
Initiates coverage on Buy $78
2021-01-26
Aegis CapitalNathan Weinstein
Initiates coverage on Buy $75

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$18.70
Market Cap
$201.97 million
52-Week Range
$7.78 – $34.10
Average Volume
169K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.